Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Ishare Nasdaq Biotech ETF (IBB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund basics

See More
  • Fund Family BlackRock
  • Assets Under Management 9,820,280,000
  • Shares Outstanding, K 92,850

Price Performance

See More
Period Period Low Period High Performance
1-Month
100.67 +5.49%
on 11/15/17
107.49 -1.20%
on 12/11/17
+2.84 (+2.75%)
since 11/13/17
3-Month
100.67 +5.49%
on 11/15/17
114.17 -6.98%
on 10/06/17
-5.14 (-4.62%)
since 09/13/17
52-Week
87.97 +20.72%
on 12/30/16
114.17 -6.98%
on 10/06/17
+16.52 (+18.42%)
since 12/13/16

Most Recent Stories

More News
Value Biotech ETFs to Buy Now

A few reasons why you should buy value biotech ETFs for 2018

BBC : 27.63 (+1.43%)
CNCR : 24.37 (+1.20%)
IBB : 106.41 (+0.61%)
VRTX : 143.54 (+1.87%)
BBH : 126.35 (+0.33%)
CLVS : 63.59 (+1.70%)
XBI : 82.35 (+0.81%)
Strongbridge Biopharma plc Added to the NASDAQ Biotech Index

Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs,...

IBB : 106.41 (+0.61%)
SBBP : 6.12 (+0.33%)
Value Biotech ETFs to Buy Now

A few reasons why you should buy value biotech ETFs for 2018

BBC : 27.63 (+1.43%)
CNCR : 24.37 (+1.20%)
IBB : 106.41 (+0.61%)
VRTX : 143.54 (+1.87%)
BBH : 126.35 (+0.33%)
CLVS : 63.59 (+1.70%)
XBI : 82.35 (+0.81%)
Aurinia Pharmaceuticals Added to the NASDAQ Biotech Index

Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH / TSX: AUP) announced today that it has been selected for addition to the NASDAQ Biotechnology Index(R) (Nasdaq:^NBI), which will become effective...

AUP.TO : 6.35 (-1.55%)
AUPH : 4.94 (-0.20%)
IBB : 106.41 (+0.61%)
Here’s What the Bulls are Buying [3 Must-See Charts]

This post Here’s What the Bulls are Buying [3 Must-See Charts] appeared first on Daily Reckoning . Dip buyers go crazy! Today, Greg Geunthner explains how to fight through the noise and discover...

IBB : 106.41 (+0.61%)
XBI : 82.35 (+0.81%)
Biotech on the Brink!

This post Biotech on the Brink! appeared first on Daily Reckoning . It’s do-or-die for biotech stocks. Today, Greg Guenthner sets the tone for the final weeks of 2017… The post Biotech on the...

BLUE : 182.75 (-4.29%)
IBB : 106.41 (+0.61%)
GILD : 76.47 (+0.50%)
REGN : 385.07 (+0.88%)
AMGN : 177.21 (+0.54%)
XBI : 82.35 (+0.81%)
Biotech ETFs: What Lies Ahead?

It's been a good year for biotech ETFs, can the rally continue?

PBE : 45.92 (+1.03%)
IBB : 106.41 (+0.61%)
FBT : 123.61 (+0.99%)
BBH : 126.35 (+0.33%)
XBI : 82.35 (+0.81%)
Biotech ETFs: What Lies Ahead?

It's been a good year for biotech ETFs, can the rally continue?

PBE : 45.92 (+1.03%)
IBB : 106.41 (+0.61%)
FBT : 123.61 (+0.99%)
BBH : 126.35 (+0.33%)
XBI : 82.35 (+0.81%)
How to Survive a Biotech Blowup

This post How to Survive a Biotech Blowup appeared first on Daily Reckoning . Big biotech stocks were primed and ready to rip higher at the beginning of the fourth quarter. But, the market threw a...

CELG : 108.23 (-0.74%)
IBB : 106.41 (+0.61%)
GILD : 76.47 (+0.50%)
REGN : 385.07 (+0.88%)
AMGN : 177.21 (+0.54%)
XBI : 82.35 (+0.81%)
BlackRock Announces Share Split for iShares Nasdaq Biotechnology ETF

BlackRock (NYSE:BLK) announces that the Board of Trustees of iShares Trust has authorized a share split for iShares Nasdaq Biotechnology ETF (IBB).

BLK : 516.90 (-0.16%)
IBB : 106.41 (+0.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

2nd Resistance Point 106.73
1st Resistance Point 106.25
Last Price 106.41
1st Support Level 105.29
2nd Support Level 104.81

See More

52-Week High 114.17
Last Price 106.41
Fibonacci 61.8% 104.16
Fibonacci 50% 101.07
Fibonacci 38.2% 97.98
52-Week Low 87.97

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.